DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $921,195 | +3.1% | 3,713 | -0.3% | 0.18% | +8.6% |
| Q2 2023 | $893,520 | -7.9% | 3,723 | -3.3% | 0.16% | -13.4% |
| Q1 2023 | $970,102 | -5.2% | 3,849 | -0.2% | 0.19% | -9.2% |
| Q4 2022 | $1,023,460 | +3.1% | 3,856 | +0.3% | 0.21% | -11.2% |
| Q3 2022 | $993,000 | -1.7% | 3,843 | -3.5% | 0.23% | +1.8% |
| Q2 2022 | $1,010,000 | -17.0% | 3,983 | -4.0% | 0.23% | -2.6% |
| Q1 2022 | $1,217,000 | -13.9% | 4,149 | -3.5% | 0.23% | -15.8% |
| Q4 2021 | $1,414,000 | +6.8% | 4,299 | -1.1% | 0.28% | -7.6% |
| Q3 2021 | $1,324,000 | +13.2% | 4,349 | -0.2% | 0.30% | +13.6% |
| Q2 2021 | $1,170,000 | +16.5% | 4,359 | -2.2% | 0.26% | +11.8% |
| Q1 2021 | $1,004,000 | +11.9% | 4,459 | +10.4% | 0.24% | +3.0% |
| Q4 2020 | $897,000 | +3.3% | 4,038 | +0.2% | 0.23% | +2.7% |
| Q3 2020 | $868,000 | +21.7% | 4,030 | 0.0% | 0.22% | +15.5% |
| Q2 2020 | $713,000 | +27.8% | 4,030 | 0.0% | 0.19% | -30.0% |
| Q1 2020 | $558,000 | -10.1% | 4,030 | -0.3% | 0.28% | +15.4% |
| Q4 2019 | $621,000 | +6.2% | 4,043 | -0.2% | 0.24% | -0.4% |
| Q3 2019 | $585,000 | +1.2% | 4,050 | +0.2% | 0.24% | -1.2% |
| Q2 2019 | $578,000 | +17.5% | 4,043 | +8.4% | 0.24% | +15.1% |
| Q1 2019 | $492,000 | +27.8% | 3,730 | 0.0% | 0.21% | +14.0% |
| Q4 2018 | $385,000 | -12.1% | 3,730 | -7.4% | 0.19% | -4.1% |
| Q3 2018 | $438,000 | +10.1% | 4,030 | 0.0% | 0.19% | +15.5% |
| Q2 2018 | $398,000 | -0.7% | 4,030 | -1.7% | 0.17% | +1.8% |
| Q1 2018 | $401,000 | -2.7% | 4,100 | -7.7% | 0.16% | -1.8% |
| Q4 2017 | $412,000 | – | 4,443 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |